# FDA 483 - Olympia Pharmaceuticals - April 13, 2018

Source: https://www.globalkeysolutions.net/records/483/olympia-pharmaceuticals/1487fd2e-82c2-4bc6-9e11-e16dfee15d39

> FDA 483 for Olympia Pharmaceuticals on April 13, 2018. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Olympia Pharmaceuticals
- Inspection Date: 2018-04-13
- Product Type: Drugs
- Office Name: Dallas District Office

## Related Documents

- [483 - 2022-03-02](https://www.globalkeysolutions.net/records/483/olympia-pharmaceuticals/0b18ee63-7a1a-4cf1-9d42-6eb34912bcb9)
- [483 - 2013-03-21](https://www.globalkeysolutions.net/records/483/olympia-pharmaceuticals/4e529ed3-cacb-4c55-a39b-d18da83f934e)
- [483 - 2024-05-28](https://www.globalkeysolutions.net/records/483/olympia-pharmaceuticals/c3a30f85-15c3-49dd-9938-5e024b7f4229)
- [483 - 2025-08-08](https://www.globalkeysolutions.net/records/483/olympia-pharmaceuticals/b1ca05d5-cc83-4795-9005-ff954f404633)

## Related Officers

- [Microbiologist](https://www.globalkeysolutions.net/people/camerson-e-moore/50733244-0d55-4b0b-a758-f192b7c66457)

Company: https://www.globalkeysolutions.net/companies/olympia-pharmaceuticals/add75b76-fde6-4e96-8a20-5c14e99a09f7

Office: https://www.globalkeysolutions.net/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9